Women's diagnostic imaging systems provider Hologic has entered into a collaborative research agreement with the David Geffen School of Medicine at the University of California, Los Angeles to study advanced breast imaging applications. The research will
Women's diagnostic imaging systems provider Hologic has entered into a collaborative research agreement with the David Geffen School of Medicine at the University of California, Los Angeles to study advanced breast imaging applications. The research will assess digital mammography workflow versus conventional film, the uses and efficiencies of a dedicated breast ultrasound system in a breast imaging practice, and the effectiveness of computer-aided detection in breast MRI. Emerging mammography technologies will also undergo clinical testing and evaluation for commercial release.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.